futibatinib 4 MG Oral Tablet [Lytgobi]
RxNorm concept 2628201, branded drug (sbd). Prescribable name: LYTGOBI 4 MG Oral Tablet.
- RxCUI
- 2628201
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2628201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- futibatinib 4 MG (SCDC, consists of)
- futibatinib 4 MG [Lytgobi] (SBDC, consists of)
- {21 (futibatinib 4 MG Oral Tablet [Lytgobi]) } Pack [Lytgobi 12 MG Daily Dose] (BPCK, contained in)
- {28 (futibatinib 4 MG Oral Tablet [Lytgobi]) } Pack [Lytgobi 16 MG Daily Dose] (BPCK, contained in)
- {35 (futibatinib 4 MG Oral Tablet [Lytgobi]) } Pack [Lytgobi 20 MG Daily Dose] (BPCK, contained in)
- {7 (futibatinib 16 MG Oral Tablet [Lytgobi]) / 7 (futibatinib 4 MG Oral Tablet [Lytgobi]) } Pack [Lytgobi 20 MG Daily Dose - 4 MG (7), 16 MG (7)] (BPCK, contained in)
- Oral Tablet (DF, has dose form)
- Lytgobi (BN, has ingredient)
- futibatinib 4 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2628201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2628201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2628201. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.